iShares Biotechnology ETF (BMV:IBB)
2,628.00
+57.99 (2.26%)
Last updated: Sep 2, 2025, 12:16 PM CST
BMV:IBB Holdings Information
BMV:IBB is an equity ETF with a total of 256 individual holdings. The top holdings are Gilead Sciences stock at 7.18%, Amgen at 6.89%, Vertex Pharmaceuticals at 6.28%, Regeneron Pharmaceuticals at 6.27%, and Alnylam Pharmaceuticals at 5.96%.
Total Holdings
256
Top 10 Percentage
47.23%
Asset Class
Equity
ETF Category
Health Care
Assets
102.93B
PE Ratio
18.93
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 7.18% |
2 | AMGN | Amgen Inc. | 6.89% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 6.28% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.27% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.96% |
6 | IQV | IQVIA Holdings Inc. | 3.38% |
7 | INSM | Insmed Incorporated | 3.17% |
8 | ARGX | argenx SE | 2.97% |
9 | MTD | Mettler-Toledo International Inc. | 2.81% |
10 | NTRA | Natera, Inc. | 2.32% |
11 | BIIB | Biogen Inc. | 2.21% |
12 | ONC | BeOne Medicines AG | 2.01% |
13 | WAT | Waters Corporation | 1.84% |
14 | UTHR | United Therapeutics Corporation | 1.84% |
15 | INCY | Incyte Corporation | 1.77% |
16 | BNTX | BioNTech SE | 1.61% |
17 | ILMN | Illumina, Inc. | 1.58% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.39% |
19 | MEDP | Medpace Holdings, Inc. | 1.20% |
20 | BMRN | BioMarin Pharmaceutical Inc. | 1.19% |
21 | GMAB | Genmab A/S | 1.17% |
22 | EXEL | Exelixis, Inc. | 1.04% |
23 | IONS | Ionis Pharmaceuticals, Inc. | 1.00% |
24 | HALO | Halozyme Therapeutics, Inc. | 0.97% |
25 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.93% |
As of Sep 3, 2025